Coronavirus and epilepsy

Autore: Dr Dora Lozsadi
Pubblicato:
Editor: Robert Smith

Approximately 600,000 people in the UK have epilepsy. As cases of COVID-19 rise across the country, many of you with epilepsy may be wondering how coronavirus may affect you.

We spoke with a leading London neurologist, Dr Dora Lozsadi, to find out some of the answers to the most frequently asked questions.

 

Epilepsy and coronavirus

Does epilepsy affect the immune system? Are epileptics more at risk of symptoms?

Epilepsy is a disease caused by overactive brain networks. This condition does not affect the immune system. However, the causes of epilepsy are multiple. Those suffering from seizures will know whether this is caused by a stroke, meningioma or past head injury. These conditions will not affect the body’s defences. However, if there is associated breathing, a swallowing problem, or additional risk from age, this does change. 

 

There are other neurological problems causing epilepsy, such as a brain tumour or vasculitis (autoimmune inflammation of blood vessels), they are treated with immunosuppressive drugs. These patients may be at increased risk, and should contact specialists prescribing their medication for further advise. Some epilepsy patients are prescribed ACTH, steroids or everolimus, these medications do affect the immune system. Your specialist will advise you if any action is needed.

 

Those vulnerable have been contacted by their GP, if not, may register: https://www.gov.uk/coronavirus-extremely-vulnerable.

 

Can the coronavirus trigger seizures?

No. Coronavirus causes infection of lung tissue (interstitial pneumonia), leading to breathing problems. Seizures may be more likely if the individual’s temperature is high. Most people with epilepsy will know their risk, i.e. may have suffered seizures in the past with other febrile illnesses. With time we expect to know more, as some infected with COVID-19 lose their sense of smell. Some treatments offered for coronavirus may interact with medication taken for epilepsy. Doctors are aware of this and can check with their pharmacist or on the ABN website.

 

What medication should epileptics take or avoid to treat symptoms?

Advise is similar to that offered to the general public. Stay at home to prevent infection, or if infected but well, avoid spreading the virus. If symptomatic (unwell) consult NHS 111 online, or your GP for further advice. Keep taking prescribed medication as recommended, and wash your hands.

 

Is it necessary to get extra epilepsy medicine in case going outside or to appointments isn’t possible?

GPs and community pharmacists are doing their utmost to ensure medication reaches people. If your stocks are low (10 days or less), please contact them over the phone. Should that fail, a local pharmacy will offer emergency supply for a couple of days. Your epilepsy nurse or specialist may also be able to help if all above fails. Ensure you have regular supplies, a reserve for a week at least) without stockpiling.

 

Should epilepsy patients on specific diets, like the ketogenic stop if they show symptoms or become ill?

There is no data to suggest a ketogenic diet puts people at risk of coronavirus infection. Restriction on travel and NHS services, however, may make monitoring a challenge. Those prescribed with a ketogenic diet should receive advice from their specialist. Some conditions (e.g. Glut 1 deficiency) require this diet as treatment of the underlying condition as well as epilepsy).
 

Regularly updated information may be found at https://www.epilepsy.org.uk/info/daily-life/safety/coronavirus-covid-19 

For more guidance or health advice in relation to neurology, you can book a consultation with Dr Dora Lozsadi via her Top Doctors profile.

*Tradotto con Google Translator. Preghiamo ci scusi per ogni imperfezione

Dr Dora Lozsadi
Neurologia

La dott.ssa Dora Lozsadi è una neurologa esperta che lavora presso il Parkside Hospital di Wimbledon, a Londra . È specializzata nell'epilessia, nella gestione dell'epilessia e nella valutazione della perdita transitoria di coscienza. Attualmente, si dedica alla ricerca sovvenzionata per Epilepsy Research UK sullo studio dell'attività cerebrale mediante elettrodi posizionati nel naso.

La dott.ssa Lozsadi ha conseguito la sua formazione specialistica presso il Walton Center for Neurology and Neurosurgery, Liverpool e l'Ospedale Nazionale di Neurologia e Neurochirurgia (UCL), a Londra. In precedenza, la dott.ssa Lozsadi ha conseguito la laurea in DPhil presso l'Università di Oxford. Attualmente è docente onorario senior presso la St George's, University of London.

Al centro dell'approccio del dott. Lozsadi sta rimuovendo lo stigma che circonda le condizioni neurologiche e dando a ogni paziente cure e cure senza pregiudizi. È stata neurologa consulente per oltre dieci anni.

*Tradotto con Google Translator. Preghiamo ci scusi per ogni imperfezione

Vedi il profilo

Valutazione generale del paziente


  • Altri trattamenti d'interesse
  • Tossina botulinica (botox)
    Neuropsicologia
    Disturbi del sonno
    Disturbi dell'apprendimento
    Acufeni
    Apnea ostruttiva del sonno
    Trattamenti neurologici
    Cefalee
    Dolore neuropatico
    Epilessia
    Questo sito web utilizza cookie propri e di terze parti per raccogliere informazioni al fine di migliorare i nostri servizi, per mostrarle la pubblicità relativa alle sue preferenze, nonché analizzare le sue abitudini di navigazione. L'utente ha la possibilità di configurare le proprie preferenze QUI.